Semin Respir Crit Care Med 2007; 28(3): 295-302
DOI: 10.1055/s-2007-981650
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Rationale for Hypertonic Saline Therapy for Cystic Fibrosis Lung Disease

Robert Tarran1 , Scott Donaldson1 , Richard C. Boucher1
  • 1Cystic Fibrosis/Pulmonary Research and Treatment Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Further Information

Publication History

Publication Date:
22 August 2007 (online)

ABSTRACT

Cystic fibrosis (CF) is caused by alterations in the CF transmembrane conductance regulator (CFTCR) gene. More than 1400 mutations in the CFTCR gene have been described, but the most common mutation (noted in 70% of CF chromosomes) is ΔF508. Alterations in the CFTCR gene result in deranged sodium and chloride ion transport channels. This leads to failure of airway epithelia to hydrate their surfaces normally, particularly in response to infectious or toxic insults. Additional effects include mucus adhesion to airway surface, chronic inflammation, and infections. The concept that airway surface dehydration can cause CF-like lung disease is supported by in vitro data and in vivo animal models. Rehydrating airway surfaces may reduce or prevent lung injury and damage. Short- and longer term studies have shown that inhalation of hypertonic saline is well tolerated and improves lung function, reduces exacerbations, and improves quality of life in CF patients. This review discusses the importance of airway epithelial sodium and chloride channels in the pathogenesis of CF, and strategies (particularly the use of inhaled hypertonic saline) to reverse or minimize lung inflammation and injury in this disease.

REFERENCES

  • 1 Davis P B. Cystic fibrosis since 1938.  Am J Respir Crit Care Med. 2006;  173 475-482
  • 2 Kerem B, Rommens J M, Buchanan J A et al.. Identification of the cystic fibrosis gene: genetic analysis.  Science. 1989;  245 1073-1080
  • 3 Riordan J R, Rommens J M, Kerem B-T et al.. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.  Science. 1989;  245 1066-1073
  • 4 Guggino W B, Stanton B A. New insights into cystic fibrosis: molecular switches that regulate CFTCR.  Nat Rev Mol Cell Biol. 2006;  7 426-436
  • 5 Anderson M P, Rich D P, Gregory R J, Smith A E, Welsh M J. Generation of cAMP-activated chloride currents by expression of CFTCR.  Science. 1991;  251 679-682
  • 6 Jia Y, Mathews C J, Hanrahan J W. Phosphorylation by protein kinase C is required for acute activation of cystic fibrosis transmembrane conductance regulator by protein kinase A.  J Biol Chem. 1997;  272 4978-4984
  • 7 Boucher R C, Stutts M J, Knowles M R, Cantley L, Gatzy J T. Na+ transport in cystic fibrosis respiratory epithelia: abnormal basal rate and response to adenylate cyclase activation.  J Clin Invest. 1986;  78 1245-1252
  • 8 Stutts M J, Canessa C M, Olsen J C et al.. CFTCR as a cAMP-dependent regulator of sodium channels.  Science. 1995;  269 847-850
  • 9 Cheng S H, Gregory R J, Marshall J et al.. Defective intracellular transport and processing of CFTCR is the molecular basis of most cystic fibrosis.  Cell. 1990;  63 827-834
  • 10 Riordan J R. Assembly of functional CFTCR chloride channels.  Annu Rev Physiol. 2005;  67 701-718
  • 11 Matsui H, Grubb B R, Tarran R et al.. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease.  Cell. 1998;  95 1005-1015
  • 12 Matsui H, Randell S H, Peretti S W, Davis C W, Boucher R C. Coordinated clearance of periciliary liquid and mucus from airway surfaces.  J Clin Invest. 1998;  102 1125-1131
  • 13 Matsui H, Davis C W, Tarran R, Boucher R C. Osmotic water permeabilities of cultured, well-differentiated normal and cystic fibrosis airway epithelia.  J Clin Invest. 2000;  105 1419-1427
  • 14 Tarran R, Trout L, Donaldson S H, Boucher R C. Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia.  J Gen Physiol. 2006;  127 591-604
  • 15 Mall M, Wissner A, Gonska T et al.. Inhibition of amiloride-sensitive epithelial Na( + ) absorption by extracellular nucleotides in human normal and cystic fibrosis airways.  Am J Respir Cell Mol Biol. 2000;  23 755-761
  • 16 Tarran R, Button B, Picher M et al.. Normal and cystic fibrosis airway surface liquid homeostasis: the effects of phasic shear stress and viral infections.  J Biol Chem. 2005;  280 35751-35759
  • 17 Tarran R, Button B, Boucher R C. Regulation of normal and cystic fibrosis airway surface liquid volume by phasic shear stress.  Annu Rev Physiol. 2006;  68 543-561
  • 18 van Ewijk B E, van der Zalm M M, Wolfs T F, van der Ent C K. Viral respiratory infections in cystic fibrosis.  J Cyst Fibros. 2005;  4(Suppl 2) 31-36
  • 19 Abman S H, Ogle J W, Butler-Simon N, Rumack C M, Accurso F J. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis.  J Pediatr. 1988;  113 826-830
  • 20 Mall M, Grubb B R, Harkema J R, O'Neal W K, Boucher R C. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.  Nat Med. 2004;  10 487-493
  • 21 Matthews L W, Spector S, Lemm J, Potter J L. Studies on pulmonary secretions, I: The overall chemical composition of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy.  Am Rev Respir Dis. 1963;  88 199-204
  • 22 Potter J L, Matthews L W, Spector S, Lemm J. Studies of pulmonary secretions, II: Osmolarity and the ionic environment of pulmonary secretions from patients with cystic fibrosis, bronchiectasis and laryngectomy.  Am Rev Respir Dis. 1967;  96 83-87
  • 23 Zuelzer W W, Newton Jr W A. The pathogenesis of fibrocystic disease of the pancreas: a study of 36 cases with special reference to the pulmonary lesions.  Pediatrics. 1949;  4 53-69
  • 24 Eng P A, Morton J, Douglass J A, Riedler J, Wilson J, Robertson C F. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.  Pediatr Pulmonol. 1996;  21 77-83
  • 25 Robinson M, Regnis J A, Bailey D L, King M, Bautovich G J, Bye P T. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.  Am J Respir Crit Care Med. 1996;  153 1503-1509
  • 26 Donaldson S H, Bennett W D, Zeman K L, Knowles M R, Tarran R, Boucher R C. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.  N Engl J Med. 2006;  354 241-250
  • 27 Elkins M R, Robinson M, Rose B R et al.. A controlled trial of long-term Inhaled hypertonic saline in patients with cystic fibrosis.  N Engl J Med. 2006;  354 229-240
  • 28 Willumsen N J, Boucher R C. Sodium transport and intracellular sodium activity in cultured human nasal epithelium.  Am J Physiol. 1991;  261(2 Pt 1) C319-C331
  • 29 Willumsen N J, Boucher R C. Transcellular sodium transport in cultured cystic fibrosis human nasal epithelium.  Am J Physiol. 1991;  261(2 Pt 1) C332-C341
  • 30 Willumsen N J, Davis C W, Boucher R C. Cellular Cl- transport in cultured cystic fibrosis airway epithelium.  Am J Physiol. 1989;  256(5 Pt 1) C1045-C1053
  • 31 Willumsen N J, Davis C W, Boucher R C. Intracellular Cl- activity and cellular Cl- pathways in cultured human airway epithelium.  Am J Physiol. 1989;  256(5 Pt 1) C1033-C1044
  • 32 Willumsen N J, Boucher R C. Shunt resistance and ion permeabilities in normal and cystic fibrosis airway epithelium.  Am J Physiol. 1989;  256(5 Pt 1) C1054-C1063
  • 33 Knowles M R, Stutts M J, Spock A, Fischer N, Gatzy J T, Boucher R C. Abnormal ion permeation through cystic fibrosis respiratory epithelium.  Science. 1983;  221 1067-1070
  • 34 Knowles M, Murray G, Shallal J et al.. Bioelectric properties and ion flow across excised human bronchi.  J Appl Physiol. 1984;  56 868-877
  • 35 Willumsen N J, Boucher R C. Activation of an apical Cl- conductance by Ca2 + ionophores in cystic fibrosis airway epithelia.  Am J Physiol. 1989;  256(2 Pt 1) C226-C233
  • 36 Levin M H, Sullivan S, Nielson D, Yang B, Finkbeiner W E, Verkman A S. Hypertonic saline therapy in cystic fibrosis: evidence against the proposed mechanism involving aquaporins.  J Biol Chem. 2006;  281 25803-25812
  • 37 Tarran R, Grubb B R, Parsons D et al.. The CF salt controversy: in vivo observations and therapeutic approaches.  Mol Cell. 2001;  8 149-158
  • 38 Sood N, Bennett W D, Zeman K et al.. Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects.  Am J Respir Crit Care Med. 2002;  167 158-163
  • 39 Knowles M R, Robinson J M, Wood R E et al.. Ion composition of airway surface liquid of patients with cystic fibrosis as compared to normal and disease-control subjects.  J Clin Invest. 1997;  100 2588-2595
  • 40 Kotaru C, Hejal R B, Finigan J H et al.. Desiccation and hypertonicity of the airway surface fluid and thermally induced asthma.  J Appl Physiol. 2003;  94 227-233

Richard C BoucherM.D. 

Cystic Fibrosis/Pulmonary Research and Treatment Center, CB#7248 7011 Thurston-Bowles Bldg.

The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7248

Email: rboucher@med.unc.edu

    >